The Bone & Joint Journal · 2016 · 86 citations · 36 references
MedicineOrthopaedic SurgeryOrthopedic SurgeryEnhanced Recovery After SurgeryOrthopedicsRehabilitationArthroplasty RehabilitationEnhanced Recovery OutcomesHip ArthroplastyHip RehabilitationPostoperative RehabilitationRehabilitation After Orthopedic SurgeryFunctional Outcome MeasurementHip Replacement RehabilitationHospital Stay DurationPostoperative Hip RehabilitationRehabilitation After Total Hip ArthroplastyShort-term Outcome Assessment
AIMS: The primary aim of this study was to investigate the effect of an enhanced recovery program (ERP) on the short-term functional outcome after total hip arthroplasty (THA). Secondary outcomes included its effect on rates of dislocation and mortality. PATIENTS AND METHODS: Data were gathered on 1161 patients undergoing primary THA which included 611 patients treated with traditional rehabilitation and 550 treated with an ERP. RESULTS: The ERP was shown to be a significant independent factor which shortened length of stay (LOS) by a mean of 1.5 days (95% confidence interval (CI) 1.3 to 1.8, p < 0.001) after adjusting for confounding variables. The rates of dislocation (traditional 1.03% vs ERP 0.91%, p = 0.84) and mortality (1.5% vs 0.6%, p = 0.14) one year post-operatively were not significantly different. Both groups showed significant improvement in Harris Hip Score (42.8 vs 41.5) at 12 to 18 months post-operatively and there was no significant difference in the magnitude of improvement on univariate (p = 0.09) and multivariate analysis (p = 0.35). There was no significant difference in any of the eight domain scores of the Short-Form - 36 general health surveys post-operatively (p > 0.38). CONCLUSION: We conclude that an ERP after THA shortens LOS by a mean of 1.5 days and does not increase the rate of complications post-operatively. It gives equivalent functional outcomes to a traditional rehabilitation pathway. TAKE HOME MESSAGE: ERP reduces LOS after THA in comparison to traditional rehabilitation, without adversely affecting functional outcomes, dislocation rates or mortality.
36